The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the HIVE Blockchain Technologies Ltd stock forecast from 3 analysts, the average analyst target price for HIVE Blockchain Technologies Ltd is USD 5.25 over the next 12 months. HIVE Blockchain Technologies Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of HIVE Blockchain Technologies Ltd is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, HIVE Blockchain Technologies Ltd’s stock price was USD 3.70. HIVE Blockchain Technologies Ltd’s stock price has changed by +1.09% over the past week, +23.75% over the past month and -30.32% over the last year.
No recent analyst target price found for HIVE Blockchain Technologies Ltd
No recent average analyst rating found for HIVE Blockchain Technologies Ltd
Company Overview HIVE Blockchain Technologies Ltd
HIVE Digital Technologies Ltd. engages in the mining and sale of digital currencies in Canada, Sweden, and Iceland. The company operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. It also provides infrastructure solutions, as well as computational capacity to distributed networks in the blockchain industry. The company was formerly known as HIVE Blockchain Technologies Ltd. and changed its name to HIVE Digital Technologies Ltd. in July 2023. HIVE Digital Technologies Ltd. was incorporated in 1987 and is headquartered in Vancouver, Canada. Read Less
HIVE Digital Technologies Ltd. engages in the mining and sale of digital currencies in Canada, Sweden, and Iceland. The company operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. It also provides infrastructure solutions, as well a...Read More
Frequently Asked Questions About HIVE Blockchain Technologies Ltd (HIVE) Stock
Based on ratings from 3 analysts HIVE Blockchain Technologies Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on HIVE's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for HIVE is USD 5.25 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 3.5.
HIVE stock's Price/Earning ratio is 3.59.
Our analysis grades HIVE stock's Price / Earning ratio at B. This means that HIVE stock's Price/Earning ratio is above 16% of the stocks in the Capital Markets sector in the NSD exchange.
Based on this HIVE may be undervalued for its sector.
The last closing price of HIVE's stock was USD 3.70.
The most recent market capitalization for HIVE is USD 0.47B.
Based on targets from 3 analysts, the average taret price for HIVE is projected at USD 5.25 over the next 12 months.
This means that HIVE's stock price may go up by +41.89% over the next 12 months.
Following are ETFs with the highest allocation to HIVE Blockchain Technologies Ltd's stock :
As per our most recent records HIVE Blockchain Technologies Ltd has 20 Employees.
HIVE Blockchain Technologies Ltd's registered address is 789 West Pender Street, Vancouver, BC, Canada, V6C 1H2.
You can get more information about it from HIVE Blockchain Technologies Ltd's website at https://hivedigitaltechnologies.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HIVE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
